Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds (Q38018268)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on October 2012

Language	Label	Description	Also known as
English	Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds	scientific article published on October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

bariatric surgery

0 references

object named as

Carel le Roux

2

0 references

author name string

Konstantinos Michalakis

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Obesity Surgery

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

1648-1657

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Current knowledge in the neurophysiologic modulation of obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Regulation of adipokine secretion by n-3 fatty acids.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Entrainment of the diurnal rhythm of plasma leptin to meal timing

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Soluble leptin receptor and leptin are associated with baseline adiposity and metabolic risk factors, and predict adiposity, metabolic syndrome, and glucose levels at 2-year follow-up: the Cyprus Metabolism Prospective Cohort Study.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Effects of leptin and adiponectin on pancreatic β-cell function

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Intracellular signalling. Key enzyme in leptin-induced anorexia

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Hypothalamic regulation of energy homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Hormonal control of the neuropeptide Y system.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Role of leptin in the activation of immune cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Gut hormones and appetite control

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Human distribution and release of a putative new gut hormone, peptide YY

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Plasma ghrelin and gastric pacing in morbidly obese patients

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

A role for ghrelin in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Differential Responses of Circulating Ghrelin to High-Fat or High-Carbohydrate Meal in Healthy Women

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Role of the duodenum and macronutrient type in ghrelin regulation

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Nutrition and L and K-enteroendocrine cells

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

On the physiology of GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Changes in gut hormones after bariatric surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

A role for the gut-to-brain GLP-1-dependent axis in the control of metabolism.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Comparison of Glucostatic Parameters After Hypocaloric Diet or Bariatric Surgery and Equivalent Weight Loss

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Postprandial changes in gut regulatory peptides in gastric bypass patients

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides.

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Preliminary report: homeostasis model assessment of insulin resistance, an indicator of insulin resistance, is strongly related to serum insulin: practical data presentation and the mathematical basis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Antagonism of ghrelin receptor reduces food intake and body weight gain in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Long-term results of bariatric restrictive procedures: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Soluble Leptin Receptor Represents the Main Leptin Binding Activity in Human Blood

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance

1 reference

https://api.crossref.org/works/10.1007%2FS11695-012-0698-9

21 January 2018

Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of PYY[3-36] in rodent models of diabetes and obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proghrelin peptides: Desacyl ghrelin is a powerful inhibitor of acylated ghrelin, likely to impair physiological effects of acyl ghrelin but not of obestatin A study of pancreatic polypeptide secretion from mouse islets

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced dietary fat clearance in postobese women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Energy homeostasis, obesity and eating disorders: recent advances in endocrinology

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early Changes in Ghrelin following Roux-en-Y Gastric Bypass: Influence of Vagal Nerve Functionality?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamic effects of oral GLP-1 and PYY3-36: a proof-of-concept study in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22692670

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11695-012-0698-9

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

release_2zxipuzckna45dye27elzp76ei

1 reference

https://api.fatcat.wiki/v0/release/2zxipuzckna45dye27elzp76ei

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38018268&oldid=2201177550"